American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Visvanathan, Kala, Chlebowski, Rowan T., Hurley, Patricia, Col, Nananda F., Ropka, Mary, Collyar, Deborah, Morrow, Monica, Runowicz, Carolyn, Pritchard, Kathleen I., Hagerty, Karen, Arun, Banu, Garber, Judy, Vogel, Victor G., Wade, James L., Brown, Powel, Cuzick, Jack, Kramer, Barnett S., Lippman, Scott M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119170/
https://ncbi.nlm.nih.gov/pubmed/19716939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.06.006
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items